Global Recombinant Zoster Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Recombinant Zoster Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Zoster Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Zoster Vaccine that contribute to its increasing demand across many markets.
The global Recombinant Zoster Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Recombinant Zoster Vaccine total production and demand, 2017-2028, (K Units)
Global Recombinant Zoster Vaccine total production value, 2017-2028, (USD Million)
Global Recombinant Zoster Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Recombinant Zoster Vaccine domestic production, consumption, key domestic manufacturers and share
Global Recombinant Zoster Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Zoster Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Recombinant Zoster Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Zoster Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Recombinant Zoster Vaccine Market, By Region:
1. How big is the global Recombinant Zoster Vaccine market?
2. What is the demand of the global Recombinant Zoster Vaccine market?
3. What is the year over year growth of the global Recombinant Zoster Vaccine market?
4. What is the production and production value of the global Recombinant Zoster Vaccine market?
5. Who are the key producers in the global Recombinant Zoster Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Recombinant Zoster Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Zoster Vaccine that contribute to its increasing demand across many markets.
The global Recombinant Zoster Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Recombinant Zoster Vaccine total production and demand, 2017-2028, (K Units)
Global Recombinant Zoster Vaccine total production value, 2017-2028, (USD Million)
Global Recombinant Zoster Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Recombinant Zoster Vaccine domestic production, consumption, key domestic manufacturers and share
Global Recombinant Zoster Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Recombinant Zoster Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Zoster Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Recombinant Zoster Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Zoster Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Recombinant Zoster Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Monovalent Vaccine
- Combination Vaccine
- Above 50 Years Old
- Below 50 Years Old
- GSK
- Merck
- Changchun Bcht Biotechnology
1. How big is the global Recombinant Zoster Vaccine market?
2. What is the demand of the global Recombinant Zoster Vaccine market?
3. What is the year over year growth of the global Recombinant Zoster Vaccine market?
4. What is the production and production value of the global Recombinant Zoster Vaccine market?
5. Who are the key producers in the global Recombinant Zoster Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Recombinant Zoster Vaccine Introduction
1.2 World Recombinant Zoster Vaccine Supply & Forecast
1.2.1 World Recombinant Zoster Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Recombinant Zoster Vaccine Production (2017-2028)
1.2.3 World Recombinant Zoster Vaccine Pricing Trends (2017-2028)
1.3 World Recombinant Zoster Vaccine Production by Region
1.3.1 World Recombinant Zoster Vaccine Production Value by Region (2017-2028)
1.3.2 World Recombinant Zoster Vaccine Production by Region (2017-2028)
1.3.3 World Recombinant Zoster Vaccine Average Price by Region (2017-2028)
1.3.4 North America Recombinant Zoster Vaccine Production (2017-2028)
1.3.5 Europe Recombinant Zoster Vaccine Production (2017-2028)
1.3.6 China Recombinant Zoster Vaccine Production (2017-2028)
1.3.7 Japan Recombinant Zoster Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Zoster Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Zoster Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Zoster Vaccine Demand (2017-2028)
2.2 World Recombinant Zoster Vaccine Consumption by Region
2.2.1 World Recombinant Zoster Vaccine Consumption by Region (2017-2022)
2.2.2 World Recombinant Zoster Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Recombinant Zoster Vaccine Consumption (2017-2028)
2.4 China Recombinant Zoster Vaccine Consumption (2017-2028)
2.5 Europe Recombinant Zoster Vaccine Consumption (2017-2028)
2.6 Japan Recombinant Zoster Vaccine Consumption (2017-2028)
2.7 South Korea Recombinant Zoster Vaccine Consumption (2017-2028)
2.8 ASEAN Recombinant Zoster Vaccine Consumption (2017-2028)
2.9 India Recombinant Zoster Vaccine Consumption (2017-2028)
3 WORLD RECOMBINANT ZOSTER VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Zoster Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Recombinant Zoster Vaccine Production by Manufacturer (2017-2022)
3.3 World Recombinant Zoster Vaccine Average Price by Manufacturer (2017-2022)
3.4 Recombinant Zoster Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Zoster Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Zoster Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Recombinant Zoster Vaccine in 2021
3.6 Recombinant Zoster Vaccine Market: Overall Company Footprint Analysis
3.6.1 Recombinant Zoster Vaccine Market: Region Footprint
3.6.2 Recombinant Zoster Vaccine Market: Company Product Type Footprint
3.6.3 Recombinant Zoster Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Zoster Vaccine Production Value Comparison
4.1.1 United States VS China: Recombinant Zoster Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Recombinant Zoster Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Recombinant Zoster Vaccine Production Comparison
4.2.1 United States VS China: Recombinant Zoster Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Recombinant Zoster Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Recombinant Zoster Vaccine Consumption Comparison
4.3.1 United States VS China: Recombinant Zoster Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Recombinant Zoster Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Recombinant Zoster Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Recombinant Zoster Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Recombinant Zoster Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Zoster Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monovalent Vaccine
5.2.2 Combination Vaccine
5.3 Market Segment by Type
5.3.1 World Recombinant Zoster Vaccine Production by Type (2017-2028)
5.3.2 World Recombinant Zoster Vaccine Production Value by Type (2017-2028)
5.3.3 World Recombinant Zoster Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Zoster Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Above 50 Years Old
6.2.2 Below 50 Years Old
6.3 Market Segment by Application
6.3.1 World Recombinant Zoster Vaccine Production by Application (2017-2028)
6.3.2 World Recombinant Zoster Vaccine Production Value by Application (2017-2028)
6.3.3 World Recombinant Zoster Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Recombinant Zoster Vaccine Product and Services
7.1.4 GSK Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Recombinant Zoster Vaccine Product and Services
7.2.4 Merck Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Changchun Bcht Biotechnology
7.3.1 Changchun Bcht Biotechnology Details
7.3.2 Changchun Bcht Biotechnology Major Business
7.3.3 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product and Services
7.3.4 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Changchun Bcht Biotechnology Recent Developments/Updates
7.3.6 Changchun Bcht Biotechnology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Recombinant Zoster Vaccine and Key Manufacturers
8.2 Recombinant Zoster Vaccine Manufacturing Costs
8.3 Recombinant Zoster Vaccine Production Process
8.4 Recombinant Zoster Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Recombinant Zoster Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Recombinant Zoster Vaccine Typical Distributors
9.3 Recombinant Zoster Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Recombinant Zoster Vaccine Introduction
1.2 World Recombinant Zoster Vaccine Supply & Forecast
1.2.1 World Recombinant Zoster Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Recombinant Zoster Vaccine Production (2017-2028)
1.2.3 World Recombinant Zoster Vaccine Pricing Trends (2017-2028)
1.3 World Recombinant Zoster Vaccine Production by Region
1.3.1 World Recombinant Zoster Vaccine Production Value by Region (2017-2028)
1.3.2 World Recombinant Zoster Vaccine Production by Region (2017-2028)
1.3.3 World Recombinant Zoster Vaccine Average Price by Region (2017-2028)
1.3.4 North America Recombinant Zoster Vaccine Production (2017-2028)
1.3.5 Europe Recombinant Zoster Vaccine Production (2017-2028)
1.3.6 China Recombinant Zoster Vaccine Production (2017-2028)
1.3.7 Japan Recombinant Zoster Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Zoster Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Zoster Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Zoster Vaccine Demand (2017-2028)
2.2 World Recombinant Zoster Vaccine Consumption by Region
2.2.1 World Recombinant Zoster Vaccine Consumption by Region (2017-2022)
2.2.2 World Recombinant Zoster Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Recombinant Zoster Vaccine Consumption (2017-2028)
2.4 China Recombinant Zoster Vaccine Consumption (2017-2028)
2.5 Europe Recombinant Zoster Vaccine Consumption (2017-2028)
2.6 Japan Recombinant Zoster Vaccine Consumption (2017-2028)
2.7 South Korea Recombinant Zoster Vaccine Consumption (2017-2028)
2.8 ASEAN Recombinant Zoster Vaccine Consumption (2017-2028)
2.9 India Recombinant Zoster Vaccine Consumption (2017-2028)
3 WORLD RECOMBINANT ZOSTER VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Zoster Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Recombinant Zoster Vaccine Production by Manufacturer (2017-2022)
3.3 World Recombinant Zoster Vaccine Average Price by Manufacturer (2017-2022)
3.4 Recombinant Zoster Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Zoster Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Zoster Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Recombinant Zoster Vaccine in 2021
3.6 Recombinant Zoster Vaccine Market: Overall Company Footprint Analysis
3.6.1 Recombinant Zoster Vaccine Market: Region Footprint
3.6.2 Recombinant Zoster Vaccine Market: Company Product Type Footprint
3.6.3 Recombinant Zoster Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Zoster Vaccine Production Value Comparison
4.1.1 United States VS China: Recombinant Zoster Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Recombinant Zoster Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Recombinant Zoster Vaccine Production Comparison
4.2.1 United States VS China: Recombinant Zoster Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Recombinant Zoster Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Recombinant Zoster Vaccine Consumption Comparison
4.3.1 United States VS China: Recombinant Zoster Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Recombinant Zoster Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Recombinant Zoster Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Recombinant Zoster Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Recombinant Zoster Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Recombinant Zoster Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Zoster Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monovalent Vaccine
5.2.2 Combination Vaccine
5.3 Market Segment by Type
5.3.1 World Recombinant Zoster Vaccine Production by Type (2017-2028)
5.3.2 World Recombinant Zoster Vaccine Production Value by Type (2017-2028)
5.3.3 World Recombinant Zoster Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Zoster Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Above 50 Years Old
6.2.2 Below 50 Years Old
6.3 Market Segment by Application
6.3.1 World Recombinant Zoster Vaccine Production by Application (2017-2028)
6.3.2 World Recombinant Zoster Vaccine Production Value by Application (2017-2028)
6.3.3 World Recombinant Zoster Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Recombinant Zoster Vaccine Product and Services
7.1.4 GSK Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Recombinant Zoster Vaccine Product and Services
7.2.4 Merck Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Changchun Bcht Biotechnology
7.3.1 Changchun Bcht Biotechnology Details
7.3.2 Changchun Bcht Biotechnology Major Business
7.3.3 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product and Services
7.3.4 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Changchun Bcht Biotechnology Recent Developments/Updates
7.3.6 Changchun Bcht Biotechnology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Recombinant Zoster Vaccine and Key Manufacturers
8.2 Recombinant Zoster Vaccine Manufacturing Costs
8.3 Recombinant Zoster Vaccine Production Process
8.4 Recombinant Zoster Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Recombinant Zoster Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Recombinant Zoster Vaccine Typical Distributors
9.3 Recombinant Zoster Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Zoster Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Recombinant Zoster Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Recombinant Zoster Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Recombinant Zoster Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Recombinant Zoster Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Recombinant Zoster Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Recombinant Zoster Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Recombinant Zoster Vaccine Production Market Share by Region (2017-2022)
Table 9. World Recombinant Zoster Vaccine Production Market Share by Region (2023-2028)
Table 10. World Recombinant Zoster Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Recombinant Zoster Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Recombinant Zoster Vaccine Major Market Trends
Table 13. World Recombinant Zoster Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Recombinant Zoster Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Recombinant Zoster Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Recombinant Zoster Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Zoster Vaccine Producers in 2021
Table 18. World Recombinant Zoster Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Recombinant Zoster Vaccine Producers in 2021
Table 20. World Recombinant Zoster Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Recombinant Zoster Vaccine Company Evaluation Quadrant
Table 22. World Recombinant Zoster Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Recombinant Zoster Vaccine Production Site of Key Manufacturer
Table 24. Recombinant Zoster Vaccine Market: Company Product Type Footprint
Table 25. Recombinant Zoster Vaccine Market: Company Product Application Footprint
Table 26. Recombinant Zoster Vaccine Competitive Factors
Table 27. Recombinant Zoster Vaccine New Entrant and Capacity Expansion Plans
Table 28. Recombinant Zoster Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Zoster Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Recombinant Zoster Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Recombinant Zoster Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Recombinant Zoster Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Recombinant Zoster Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Recombinant Zoster Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Recombinant Zoster Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Recombinant Zoster Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Recombinant Zoster Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Recombinant Zoster Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Recombinant Zoster Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Recombinant Zoster Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Recombinant Zoster Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Recombinant Zoster Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Recombinant Zoster Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Recombinant Zoster Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Recombinant Zoster Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Recombinant Zoster Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Recombinant Zoster Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Recombinant Zoster Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Recombinant Zoster Vaccine Product and Services
Table 64. GSK Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Recombinant Zoster Vaccine Product and Services
Table 70. Merck Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Merck Recent Developments/Updates
Table 72. Changchun Bcht Biotechnology Basic Information, Manufacturing Base and Competitors
Table 73. Changchun Bcht Biotechnology Major Business
Table 74. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product and Services
Table 75. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Recombinant Zoster Vaccine Raw Material
Table 77. Key Manufacturers of Recombinant Zoster Vaccine Raw Materials
Table 78. Recombinant Zoster Vaccine Typical Distributors
Table 79. Recombinant Zoster Vaccine Typical Customers
Table 1. World Recombinant Zoster Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Recombinant Zoster Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Recombinant Zoster Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Recombinant Zoster Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Recombinant Zoster Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Recombinant Zoster Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Recombinant Zoster Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Recombinant Zoster Vaccine Production Market Share by Region (2017-2022)
Table 9. World Recombinant Zoster Vaccine Production Market Share by Region (2023-2028)
Table 10. World Recombinant Zoster Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Recombinant Zoster Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Recombinant Zoster Vaccine Major Market Trends
Table 13. World Recombinant Zoster Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Recombinant Zoster Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Recombinant Zoster Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Recombinant Zoster Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Zoster Vaccine Producers in 2021
Table 18. World Recombinant Zoster Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Recombinant Zoster Vaccine Producers in 2021
Table 20. World Recombinant Zoster Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Recombinant Zoster Vaccine Company Evaluation Quadrant
Table 22. World Recombinant Zoster Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Recombinant Zoster Vaccine Production Site of Key Manufacturer
Table 24. Recombinant Zoster Vaccine Market: Company Product Type Footprint
Table 25. Recombinant Zoster Vaccine Market: Company Product Application Footprint
Table 26. Recombinant Zoster Vaccine Competitive Factors
Table 27. Recombinant Zoster Vaccine New Entrant and Capacity Expansion Plans
Table 28. Recombinant Zoster Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Zoster Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Recombinant Zoster Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Recombinant Zoster Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Recombinant Zoster Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Recombinant Zoster Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Recombinant Zoster Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Recombinant Zoster Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Recombinant Zoster Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Recombinant Zoster Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Recombinant Zoster Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Recombinant Zoster Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Recombinant Zoster Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Recombinant Zoster Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Recombinant Zoster Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Recombinant Zoster Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Recombinant Zoster Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Recombinant Zoster Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Recombinant Zoster Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Recombinant Zoster Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Recombinant Zoster Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Recombinant Zoster Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Recombinant Zoster Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Recombinant Zoster Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Recombinant Zoster Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Recombinant Zoster Vaccine Product and Services
Table 64. GSK Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Recombinant Zoster Vaccine Product and Services
Table 70. Merck Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Merck Recent Developments/Updates
Table 72. Changchun Bcht Biotechnology Basic Information, Manufacturing Base and Competitors
Table 73. Changchun Bcht Biotechnology Major Business
Table 74. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product and Services
Table 75. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Recombinant Zoster Vaccine Raw Material
Table 77. Key Manufacturers of Recombinant Zoster Vaccine Raw Materials
Table 78. Recombinant Zoster Vaccine Typical Distributors
Table 79. Recombinant Zoster Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Recombinant Zoster Vaccine Picture
Figure 2. World Recombinant Zoster Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Recombinant Zoster Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 5. World Recombinant Zoster Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Recombinant Zoster Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Recombinant Zoster Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 10. China Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 12. Recombinant Zoster Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Zoster Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Recombinant Zoster Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Recombinant Zoster Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Zoster Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Zoster Vaccine Markets in 2021
Figure 26. United States VS China: Recombinant Zoster Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Recombinant Zoster Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Recombinant Zoster Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Recombinant Zoster Vaccine in United States
Figure 30. Key Producers and Market Share of Recombinant Zoster Vaccine in China
Figure 31. Key Producers and Market Share of Recombinant Zoster Vaccine in Rest of World
Figure 32. World Recombinant Zoster Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Recombinant Zoster Vaccine Production Value Market Share by Type in 2021
Figure 34. Monovalent Vaccine
Figure 35. Combination Vaccine
Figure 36. World Recombinant Zoster Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Recombinant Zoster Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Recombinant Zoster Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Recombinant Zoster Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Recombinant Zoster Vaccine Production Value Market Share by Application in 2021
Figure 41. Above 50 Years Old
Figure 42. Below 50 Years Old
Figure 43. World Recombinant Zoster Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Recombinant Zoster Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Recombinant Zoster Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Recombinant Zoster Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Recombinant Zoster Vaccine
Figure 48. Recombinant Zoster Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Recombinant Zoster Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Recombinant Zoster Vaccine Picture
Figure 2. World Recombinant Zoster Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Recombinant Zoster Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 5. World Recombinant Zoster Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Recombinant Zoster Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Recombinant Zoster Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 10. China Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Recombinant Zoster Vaccine Production (2017-2028) & (K Units)
Figure 12. Recombinant Zoster Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Zoster Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Recombinant Zoster Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Recombinant Zoster Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Recombinant Zoster Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Zoster Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Zoster Vaccine Markets in 2021
Figure 26. United States VS China: Recombinant Zoster Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Recombinant Zoster Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Recombinant Zoster Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Recombinant Zoster Vaccine in United States
Figure 30. Key Producers and Market Share of Recombinant Zoster Vaccine in China
Figure 31. Key Producers and Market Share of Recombinant Zoster Vaccine in Rest of World
Figure 32. World Recombinant Zoster Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Recombinant Zoster Vaccine Production Value Market Share by Type in 2021
Figure 34. Monovalent Vaccine
Figure 35. Combination Vaccine
Figure 36. World Recombinant Zoster Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Recombinant Zoster Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Recombinant Zoster Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Recombinant Zoster Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Recombinant Zoster Vaccine Production Value Market Share by Application in 2021
Figure 41. Above 50 Years Old
Figure 42. Below 50 Years Old
Figure 43. World Recombinant Zoster Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Recombinant Zoster Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Recombinant Zoster Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Recombinant Zoster Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Recombinant Zoster Vaccine
Figure 48. Recombinant Zoster Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Recombinant Zoster Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
